AMENDMENT NO. 3 TO COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • August 5th, 2011 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
THIS AMENDMENT NO. 3 TO COLLABORATION AND LICENSE AGREEMENT (this “Amendment”), effective as of the 1st day of April, 2011 (the “Amendment Effective Date”), is entered into by and between Momenta Pharmaceuticals, Inc., a Delaware corporation with a principal place of business at 675 West Kendall Street, Cambridge, MA 02142 USA (“Momenta”), and Sandoz AG, a Swiss corporation with a principal place of business at Lichtstraße 35, CH 4056 Basel BS, Switzerland (“Sandoz”).
AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 5th, 2011 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Amendment No. 2 (the “Amendment”) to the Asset Purchase Agreement (the “Agreement”) dated April 20, 2007 by and among MOMENTA PHARMACEUTICALS, INC., a Delaware corporation (the “Buyer”), PARIVID, LLC, a Massachusetts limited liability company (the “Seller”) and S. RAGURAM, an individual (“Primary Member”) is entered into as of July 18, 2011.
